PreveCeutical Medical is an early stage biotech with ample risk in a nascent development pipeline. Nonetheless, the Company has made progress with its development projects, demonstrating the ability of the scientific team to execute on the R&D agenda. Highest priority on the Company’s agenda is a non-opioid pain treatment compound based on cannabinoids and administered […]
Category: PREV
Updated Coverage – PreveCeutical Medical (PRVCF)
Our coverage of PreveCeutical Medical (PRVCF) is updated with comments on recent progress with the Company’s portfolio of research and development projects focused on preventative therapeutics. The Company has several major achievements in recent months, moving the R&D pipeline closer to goals. In March 2018, the Company’s research and development partner UniQuest Pty. Ltd. began […]
New Coverage – PreveCeutical Medical (PRVCF)
PreveCeutical Medical is biomedical company focused on preventative health sciences using organic and nature-identical compounds. The Company was recently organized to pursue market opportunities for a novel therapy based on blue scorpion venom. PreveCeutical markets an CELLB9, an oral solution of blue scorpion venom for use without prescription. The solution has been found instrumental in […]